Spots Global Cancer Trial Database for anatomic stage iii breast cancer ajcc v8

Every month we try and update this database with for anatomic stage iii breast cancer ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	NCT02453620	Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid...	Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial	NCT06016725	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Stage I Colorec... Stage I Prostat... Stage II Colore... Stage II Prosta... Stage III Color... Stage III Prost...	Exercise Interv... Informational I... Nutritional Ass... Physical Perfor... Quality-of-Life... Questionnaire A...	65 Years -	Ohio State University Comprehensive Cancer Center
Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer	NCT05945290	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Early Stage Bre... Locally Advance...	Biospecimen Col... Electronic Heal...	18 Years -	Mayo Clinic
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment	NCT05928325	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ...	Comprehensive G... Health Educatio... Medical Device ... Supportive Care	65 Years -	M.D. Anderson Cancer Center
A QoL Intervention for Young African American Breast Cancer Survivors	NCT05452681	Breast Cancer Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Educational Int... Quality-of-Life... Questionnaire A... Control Interve...	18 Years - 44 Years	Ohio State University Comprehensive Cancer Center
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer	NCT05368428	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Chemotherapy-In... Early Stage Bre... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Transcutaneous ...	18 Years -	Emory University
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors	NCT06392789	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Insomnia	Cognitive Behav... Internet-Based ... Medical Device ... Questionnaire A... Text Message-Ba...	18 Years -	University of Washington
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer	NCT03939481	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Lung Non-Small ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage I Lung Ca... Stage I Ovarian... Stage IA Ovaria... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage IB Ovaria... Stage IC Ovaria... Stage II Lung C... Stage II Ovaria... Stage IIA Lung ... Stage IIA Ovari... Stage IIB Lung ... Stage IIB Ovari... Stage III Lung ... Stage III Ovari... Stage IIIA Lung... Stage IIIA Ovar... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Lung... Stage IIIB Ovar... Stage IIIC Lung... Stage IIIC Ovar...	Chemotherapy Functional Asse... Questionnaire A...	18 Years -	SWOG Cancer Research Network
Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer	NCT00507923	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Breast Cancer	Actigraph Best Practice Quality-of-Life... Questionnaire A... Sleep Diary Stretching Yoga	18 Years -	M.D. Anderson Cancer Center
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	NCT02453620	Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid...	Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer	NCT05547347	Anatomic Stage ... Locally Advance... Resectable Brea...	Magnetic Resona... Mammogram Ultrasound Ultrasound-Guid...	18 Years -	Mayo Clinic
Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer	NCT04249167	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Locally Advance... Metastatic Trip... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Atezolizumab Cryosurgery Nab-paclitaxel	18 Years -	Mayo Clinic
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial	NCT04704661	Advanced Breast... Advanced Colon ... Advanced Colore... Advanced Endome... Advanced Gastri... Advanced Gastro... Advanced Malign... Advanced Saliva... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... HER2-Positive B... Malignant Hepat... Metastatic Brea... Metastatic Gast... Metastatic Mali... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Colon... Stage III Color... Stage III Major... Stage III Uteri... Stage IIIA Colo... Stage IIIA Colo... Stage IIIA Uter... Stage IIIB Colo... Stage IIIB Colo... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Colo... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Colon ... Stage IV Colore... Stage IV Major ... Stage IV Uterin... Stage IVA Colon... Stage IVA Color... Stage IVA Major... Stage IVA Uteri... Stage IVB Colon... Stage IVB Color... Stage IVB Major... Stage IVB Uteri... Stage IVC Colon... Stage IVC Color... Stage IVC Major... Unresectable Co... Unresectable Ga... Unresectable Ma...	Ceralasertib Trastuzumab Der...	18 Years -	National Cancer Institute (NCI)
Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment	NCT04862195	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Stage I Lung Ca... Stage II Lung C... Stage III Lung ...	Attune™ Cerena™	18 Years - 75 Years	Blue Note Therapeutics
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy	NCT04927559	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Survey Administ...	18 Years -	University of Southern California
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer	NCT04001829	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Docetaxel Paclitaxel Quality-of-Life... Questionnaire A...	18 Years -	Eastern Cooperative Oncology Group
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer	NCT04491942	Advanced Bile D... Advanced Breast... Advanced Cervic... Advanced Endome... Advanced Esopha... Advanced Gastri... Advanced Head a... Advanced Lung N... Advanced Lung S... Advanced Malign... Advanced Ovaria... Advanced Penile... Advanced Pleura... Advanced Urothe... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Stage III Cervi... Stage III Dista... Stage III Intra... Stage III Lung ... Stage III Ovari... Stage III Penil... Stage III Pleur... Stage IV Cervic... Stage IV Distal... Stage IV Intrah... Stage IV Lung C... Stage IV Ovaria... Stage IV Penile... Stage IV Pleura... Triple-Negative... Unresectable Ur...	Cisplatin Elimusertib Gemcitabine Hyd...	18 Years -	National Cancer Institute (NCI)
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy	NCT04379570	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2 Negative B... Hormone Recepto... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Educational Int... Text Message-ba... Motivational In... Best Practice Questionnaire A... Quality-of-Life...	18 Years -	Alliance for Clinical Trials in Oncology
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy	NCT06401889	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Estrogen Recept... Progesterone Re...	Non-Interventio...	18 Years -	Mayo Clinic
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy	NCT06401889	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Estrogen Recept... Progesterone Re...	Non-Interventio...	18 Years -	Mayo Clinic
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV	NCT04514484	Advanced Differ... Advanced Head a... Advanced Hepato... Advanced Kaposi... Advanced Lung N... Advanced Lung S... Advanced Malign... Advanced Melano... Advanced Ovaria... Advanced Prosta... Advanced Renal ... Advanced Thyroi... Advanced Triple... Advanced Urothe... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Clinical Stage ... Clinical Stage ... HIV Infection Metastatic Diff... Metastatic Head... Metastatic Hepa... Metastatic Kapo... Metastatic Lung... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Ovar... Metastatic Pros... Metastatic Rena... Metastatic Thyr... Metastatic Trip... Metastatic Urot... Recurrent Diffe... Recurrent Head ... Recurrent Hepat... Recurrent Kapos... Recurrent Lung ... Recurrent Lung ... Recurrent Malig... Recurrent Melan... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Thyro... Recurrent Tripl... Recurrent Uroth... Refractory Diff... Stage III Diffe... Stage III Hepat... Stage III Lung ... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Thyro... Stage IV Differ... Stage IV Hepato... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Thyroi...	Biospecimen Col... Cabozantinib S-... Computed Tomogr... Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial	NCT05710328	Anatomic Stage ... Anatomic Stage ... HER2-Positive B... Invasive Breast...	Chemotherapy Computed Tomogr... Fludeoxyglucose... Positron Emissi... Surgical Proced...	18 Years -	Eastern Cooperative Oncology Group
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer	NCT03941730	Advanced Triple... Anatomic Stage ... Anatomic Stage ... Metastatic Trip... Recurrent Breas...	Biopsy Computed Tomogr... Magnetic Resona... Positron Emissi... Therapeutic Est...	18 Years -	Mayo Clinic
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer	NCT03774472	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Hydroxychloroqu... Letrozole Palbociclib	18 Years -	M.D. Anderson Cancer Center
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax	NCT05092373	Advanced Breast... Advanced Endome... Advanced Fallop... Advanced Hepato... Advanced Malign... Advanced Malign... Advanced Malign... Advanced Ovaria... Advanced Primar... Advanced Renal ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Malignant Abdom... Malignant Solid... Metastatic Brea... Metastatic Endo... Metastatic Fall... Metastatic Hepa... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Ovar... Metastatic Prim... Metastatic Rena... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Fallo... Stage III Hepat... Stage III Ovari... Stage III Prima... Stage III Renal... Stage III Uteri... Stage IIIA Fall... Stage IIIA Hepa... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIA1 Fal... Stage IIIA1 Ova... Stage IIIA2 Fal... Stage IIIA2 Ova... Stage IIIB Fall... Stage IIIB Hepa... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Fallop... Stage IV Hepato... Stage IV Ovaria... Stage IV Primar... Stage IV Renal ... Stage IV Uterin... Stage IVA Fallo... Stage IVA Hepat... Stage IVA Ovari... Stage IVA Prima... Stage IVA Uteri... Stage IVB Fallo... Stage IVB Hepat... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri...	Atezolizumab Cabozantinib S-... Nab-paclitaxel Tumor Treating ...	18 Years -	M.D. Anderson Cancer Center
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer	NCT05183828	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast...	Biospecimen Col... Letrozole Questionnaire A...	18 Years -	University of Washington
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study	NCT04593277	Clinical Stage ... Clinical Stage ... Clinical Stage ... Hematopoietic a... Invasive Malign... Leukemia Lymphoma Malignant Solid... Sarcoma Stage I Colorec... Stage II Colore... Stage III Color... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Thyroid Gland C...	Internet Mobile... Internet-Based ... Questionnaire A... Supportive Care Informational I...	18 Years -	Fred Hutchinson Cancer Center
Testing the Addition of Copanlisib to Eribulin for the Treatment of Advanced-Stage Triple Negative Breast Cancer	NCT04345913	Anatomic Stage ... Anatomic Stage ... Metastatic Trip... Unresectable Tr...	Biopsy Biospecimen Col... Computed Tomogr... Copanlisib Hydr... Eribulin Mesyla... Magnetic Resona...	18 Years -	National Cancer Institute (NCI)
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer	NCT05422794	Anatomic Stage ... Anatomic Stage ... Locally Advance... Metastatic Trip... Unresectable Tr...	BET Bromodomain... Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Nab-paclitaxel Pembrolizumab	18 Years -	National Cancer Institute (NCI)
Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer	NCT04205071	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Chemotherapy-In... Digestive Syste... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Lorcaserin Lorcaserin Hydr... Questionnaire A...	18 Years -	Ohio State University Comprehensive Cancer Center
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer	NCT05177796	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Inflamma... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Triple-Negative...	Carboplatin Cyclophosphamid... Doxorubicin Paclitaxel Panitumumab Pembrolizumab	18 Years -	M.D. Anderson Cancer Center
Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer	NCT04249622	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2 Positive B... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Best Practice Questionnaire A... Rifaximin	18 Years -	Mayo Clinic
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial	NCT05564377	Advanced Malign... Anatomic Stage ... Anatomic Stage ... Locally Advance... Malignant Femal... Metastatic HER2... Metastatic Mali... Recurrent Endom... Recurrent Fallo... Recurrent Malig... Recurrent Malig... Recurrent Ovari... Recurrent Prima... Unresectable HE... Unresectable Ma...	Alpelisib Binimetinib Biopsy Biospecimen Col... Bone Marrow Asp... Bone Scan Computed Tomogr... Echocardiograph... Fluorouracil Fulvestrant Ipatasertib Leucovorin Magnetic Resona... Multigated Acqu... Mutation Carrie... Neratinib Malea... Nilotinib Hydro... Olaparib Oxaliplatin Paclitaxel Palbociclib Panitumumab Positron Emissi... Selumetinib Sul... Sotorasib	-	National Cancer Institute (NCI)
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer	NCT03774472	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Hydroxychloroqu... Letrozole Palbociclib	18 Years -	M.D. Anderson Cancer Center
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer	NCT03939481	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Lung Non-Small ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage I Lung Ca... Stage I Ovarian... Stage IA Ovaria... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage IB Ovaria... Stage IC Ovaria... Stage II Lung C... Stage II Ovaria... Stage IIA Lung ... Stage IIA Ovari... Stage IIB Lung ... Stage IIB Ovari... Stage III Lung ... Stage III Ovari... Stage IIIA Lung... Stage IIIA Ovar... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Lung... Stage IIIB Ovar... Stage IIIC Lung... Stage IIIC Ovar...	Chemotherapy Functional Asse... Questionnaire A...	18 Years -	SWOG Cancer Research Network
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer	NCT06324240	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Early Stage Tri... Locally Advance... Metastatic Trip... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Recurrent Breas... Unresectable Tr...	Ipilimumab Pembrolizumab Vaccine Therapy	18 Years -	Emory University
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer	NCT04673448	Anatomic Stage ... Anatomic Stage ... BRCA-Associated... BRCA-Associated... Metastatic BRCA... Metastatic Brea... Metastatic Fall... Metastatic Mali... Metastatic Ovar... Metastatic Panc... Metastatic Prim... Prognostic Stag... Prognostic Stag... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Br... Unresectable Fa... Unresectable Ma... Unresectable Ov... Unresectable Pa... Unresectable Pr...	Dostarlimab Niraparib	18 Years -	University of Washington
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery	NCT03218826	Advanced Breast... Advanced Malign... Advanced Prosta... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Metastatic Brea... Metastatic Mali... Metastatic Pros... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Triple-Negative... Unresectable So...	Docetaxel Laboratory Biom... Pharmacological... PI3Kbeta Inhibi...	18 Years -	National Cancer Institute (NCI)
Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors	NCT04906200	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Best Practice Internet-Based ... Survey Administ...	15 Years - 39 Years	Ohio State University Comprehensive Cancer Center
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study	NCT03707574	Advanced Malign... Advanced Melano... Advanced Renal ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Color... Stage III Lung ... Stage III Ovari... Stage III Prost... Stage IIIA Colo... Stage IIIA Lung... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Colo... Stage IIIB Lung... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Colo... Stage IIIC Lung... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IVA Color... Stage IVA Lung ... Stage IVA Ovari... Stage IVA Prost... Stage IVB Color... Stage IVB Lung ... Stage IVB Ovari... Stage IVB Prost... Stage IVC Color...	Biospecimen Col...	18 Years -	National Cancer Institute (NCI)
Remotely Delivered, Culturally Tailored Weight Loss Interventions Among Latina Breast Cancer Survivors	NCT05930483	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ...	Behavioral Diet... Behavioral Inte... Biospecimen Col... Dietary Interve... Educational Int... Exercise Interv... Health Promotio... Internet-Based ... Interview Lifestyle Couns... Medical Device ... Medical Device ... Nutritional Int... Questionnaire A... Telephone-Based...	18 Years -	Fred Hutchinson Cancer Center
Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery	NCT05327608	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... HER2 Negative B... Hormone Recepto... Invasive Breast...	Short-Term Fast...	18 Years -	Thomas Jefferson University
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer	NCT06179303	Anatomic Stage ... Anatomic Stage ... Locally Advance... Locally Advance... Metastatic HER2... Metastatic Horm...	Abemaciclib Anastrozole Biospecimen Col... Computed Tomogr... Diagnostic Imag... Exemestane Fludeoxyglucose... Fluorine F 18 F... Fulvestrant Gonadotropin-re... Letrozole Positron Emissi... Tamoxifen Therapeutic Est...	18 Years -	University of Washington
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer	NCT03774472	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Hydroxychloroqu... Letrozole Palbociclib	18 Years -	M.D. Anderson Cancer Center
Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors	NCT04999826	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Biospecimen Col... Quality-of-Life... Questionnaire A...	18 Years - 75 Years	Mayo Clinic
Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer	NCT05086731	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Localized Breas... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Triple-Negative... Metastatic Brea...	Best Practice Informational I... Medical Device ... Quality-of-Life... Survey Administ...	18 Years -	Emory University
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy	NCT04379570	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2 Negative B... Hormone Recepto... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Educational Int... Text Message-ba... Motivational In... Best Practice Questionnaire A... Quality-of-Life...	18 Years -	Alliance for Clinical Trials in Oncology
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer	NCT02918474	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Ductal Breast C... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Sporadic Breast...	Decision Aid Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer	NCT04693338	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ...	Quality-of-Life... Questionnaire A... Supportive Care	18 Years -	Mayo Clinic
Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery	NCT05327608	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Ductal C... HER2 Negative B... Hormone Recepto... Invasive Breast...	Short-Term Fast...	18 Years -	Thomas Jefferson University
Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer	NCT03505736	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Premenopausal Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Adenosine Magnetic Resona... Regadenoson Stress Manageme...	- 55 Years	Wake Forest University Health Sciences
Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations	NCT04216472	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Refractory Brea... Triple-Negative...	Alpelisib Nab-paclitaxel	18 Years -	M.D. Anderson Cancer Center
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer	NCT05464810	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2-Negative B... Hormone Recepto... Invasive Breast...	Letrozole Simvastatin	18 Years -	Emory University
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer	NCT04001829	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Docetaxel Paclitaxel Quality-of-Life... Questionnaire A...	18 Years -	Eastern Cooperative Oncology Group
Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment	NCT04862195	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Stage I Lung Ca... Stage II Lung C... Stage III Lung ...	Attune™ Cerena™	18 Years - 75 Years	Blue Note Therapeutics
Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer	NCT05025059	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Discussion Exercise Interv... Exercise Interv... Informational I... Informational I... Medical Device ... Quality-of-Life... Questionnaire A...	65 Years -	M.D. Anderson Cancer Center
Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain	NCT05412953	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ...	Questionnaire A... Tonation Breath...	18 Years -	Mayo Clinic
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer	NCT04705025	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Lung Non-Small ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung...	Cognitive Behav... Interview Quality-of-Life... Questionnaire A...	18 Years -	Jonsson Comprehensive Cancer Center
Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors	NCT04999826	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Biospecimen Col... Quality-of-Life... Questionnaire A...	18 Years - 75 Years	Mayo Clinic
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors	NCT05595499	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ...	Biospecimen Col... Fisetin Placebo Adminis... Quality-of-Life... Questionnaire A...	-	Jonsson Comprehensive Cancer Center
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial	NCT05379153	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Vaginal Atrophy	Laser Therapy Sham Interventi... Questionnaire A... Quality of Life...	22 Years -	Alliance for Clinical Trials in Oncology
An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutrition Information	NCT06193070	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ...	Educational Int... Interview Survey Administ... Telemedicine	18 Years -	Fred Hutchinson Cancer Center
Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer	NCT05244434	Advanced Breast... Advanced HER2-N... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Hormone Recepto... Metastatic Brea... Metastatic HER2... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Best Practice Biopsy Biospecimen Col... Laboratory Biom...	18 Years -	City of Hope Medical Center
Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions	NCT04549571	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Decision Aid iC... Decision Aid iC... Therapeutic Con... Interview Training Media Intervent... Best Practice Survey Administ... Quality-of-Life...	-	Alliance for Clinical Trials in Oncology
Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer	NCT02849496	Anatomic Stage ... Anatomic Stage ... Locally Advance... Locally Advance... Metastatic Brea... Metastatic HER2... Unresectable Br... Unresectable HE...	Atezolizumab Biopsy Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Bone Scan Computed Tomogr... Magnetic Resona... Olaparib Positron Emissi... Questionnaire A... X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
National Cancer Institute "Cancer Moonshot Biobank"	NCT04314401	Acute Myeloid L... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Lung Non-Small ... Lung Small Cell... Malignant Solid... Metastatic Pros... Multiple Myelom... Stage III Lung ... Stage III Ovari... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IVB Prost...	Biospecimen Col... Medical Chart R...	13 Years -	National Cancer Institute (NCI)
Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer	NCT04693338	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ...	Quality-of-Life... Questionnaire A... Supportive Care	18 Years -	Mayo Clinic
Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)	NCT06106282	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Hormone Recepto...	Non-Interventio...	18 Years -	Mayo Clinic
A Quality of Life Intervention (Y-AMBIENT) for Young African American With Stage I-III Breast Cancer	NCT05243056	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Best Practice Educational Int... Quality-of-Life... Questionnaire A...	18 Years - 44 Years	Ohio State University Comprehensive Cancer Center
Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors	NCT04200482	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	One Diet and Ph... Electronic (e) ... Twelve Diet and... Questionnaire A... Quality-of-Life...	18 Years -	Fred Hutchinson Cancer Center
EXERCISING TOGETHER for Couples Coping With Cancer	NCT03630354	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Breast Carcinom... Colorectal Carc... Malignant Solid... Prostate Carcin... Stage I Colorec... Stage I Prostat... Stage II Colore... Stage II Prosta... Stage III Color... Stage III Prost...	Exercise Interv... Exercise Interv... Informational I... Questionnaire A...	35 Years - 80 Years	OHSU Knight Cancer Institute
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial	NCT06042569	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2-Negative B...	Cyclophosphamid... Docetaxel Medical Chart R... Questionnaire A...	65 Years -	City of Hope Medical Center
Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors	NCT04560439	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Early-Stage Bre... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Dietary Interve...	18 Years - 75 Years	City of Hope Medical Center
National Cancer Institute "Cancer Moonshot Biobank"	NCT04314401	Acute Myeloid L... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Lung Non-Small ... Lung Small Cell... Malignant Solid... Metastatic Pros... Multiple Myelom... Stage III Lung ... Stage III Ovari... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IVB Prost...	Biospecimen Col... Medical Chart R...	13 Years -	National Cancer Institute (NCI)
Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients	NCT04443413	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ...	Proton Beam Rad... Questionnaire A... X-ray Therapy	18 Years -	Mayo Clinic
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial	NCT06042569	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... HER2-Negative B...	Cyclophosphamid... Docetaxel Medical Chart R... Questionnaire A...	65 Years -	City of Hope Medical Center
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer	NCT04329065	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	pUMVC3-IGFBP2-H... Paclitaxel Trastuzumab Pertuzumab	18 Years -	University of Washington
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer	NCT05417308	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Endocrine Thera... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Minoxidil Minoxidil Quality-of-Life... Questionnaire A...	18 Years -	Ohio State University Comprehensive Cancer Center
Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer	NCT03505671	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Grade 1 Periphe... Grade 1 Periphe... Grade 2 Periphe... Grade 2 Periphe... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Acupuncture The... Best Practice Quality-of-Life... Questionnaire A...	18 Years -	Wake Forest University Health Sciences
Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors	NCT05674578	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Patient Navigat... Quality-of-Life... Questionnaire A...	18 Years -	Ohio State University Comprehensive Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: